Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "virus"

478 News Found

MicroLumix’ GermPass kills Covid-19 virus in five seconds
Medical Device | February 23, 2022

MicroLumix’ GermPass kills Covid-19 virus in five seconds

New biotechnology product aims to be world's fastest automatic sanitary solution


Asahi Kasei to build new production unit for membrane virus filters in Japan
News | February 22, 2022

Asahi Kasei to build new production unit for membrane virus filters in Japan

The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market


Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines
News | February 22, 2022

Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines

Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply


Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus
News | February 21, 2022

Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus

CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan


MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
Drug Approval | September 29, 2021

MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9

India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys


DCGI grants EUA to Truenat for conducting Nipah virus tests
Digitisation | September 09, 2021

DCGI grants EUA to Truenat for conducting Nipah virus tests

Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis


Sharp develops Plasmacluster tech that reduces airborne novel coronavirus
Drug Approval | September 07, 2021

Sharp develops Plasmacluster tech that reduces airborne novel coronavirus

Plasmacluster technology significantly inactivates SARS-CoV-2 contained in adherent saliva in an environment with 60% humidity where the physiological protective function is maintained


Pfizer announces Phase 3 clinical trial for vaccine against Respiratory Syncytial Virus (RSV)
Drug Approval | September 03, 2021

Pfizer announces Phase 3 clinical trial for vaccine against Respiratory Syncytial Virus (RSV)

RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available


Takeda and Frazier Healthcare Partners collaborates for Norovirus vaccine candidate
Biotech | August 02, 2021

Takeda and Frazier Healthcare Partners collaborates for Norovirus vaccine candidate

Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines


Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test
News | October 30, 2025

Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test

Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks